Diazo Transfer From Nitrous Oxide Employing Phosphorus Ylides. [PDF]
A phosphorus ylide‐mediated strategy achieves the direct fixation of nitrous oxide (N2O) to access diazo compounds, which after intra‐ or intermolecular trapping, afford N2‐containing organic building blocks. This approach provides an alternative to hazardous diazo‐transfer reagents and establishes N2O fixation as a sustainable methodology.
Yu JK +4 more
europepmc +3 more sources
Phytochemical Characterization and Neuropharmacological Assessment of <i>Combretum indicum</i> Methanolic Extract With Integrated Molecular Docking and Dynamics Simulation for Anxiety and Depression Therapy. [PDF]
Islam Z +5 more
europepmc +1 more source
Evaluation of the Insecticidal Activity, Formulation, and Computational Study of Some Hydrazone and Pyridazin-3(2H)-one Derivatives. [PDF]
Ismail MF +5 more
europepmc +1 more source
Novel Competitive, Nonpeptidic, SARS-CoV‑2 M<sup>pro</sup> Inhibitors with Improved Solubility. [PDF]
Sahin Z +7 more
europepmc +1 more source
Discovery of Sulfonamide Pantothenate Kinase Activators and Elucidation of the Role of Isoform Selectivity in Cellular Pantothenate Kinase Activation. [PDF]
Coker AL +11 more
europepmc +1 more source
Development of Pyrimido Pyridazine Analogs through Increased Whole Cell Target Engagement of the Dihydropteroate Synthase Pterin Binding Site in Gram-Negative Bacteria. [PDF]
Snoke HE +11 more
europepmc +1 more source
Synthesis, crystal structure and DFT study of carbon-yl[3-(dibenzo[<i>b</i>,<i>d</i>]thio-phen-4-yl)-6-(pyridin-2-yl-κ<i>N</i>)pyridazine-κ<i>N</i> <sup>1</sup>]bis-(tri-methyl-phosphane)iron(0). [PDF]
Futaki R +2 more
europepmc +1 more source
Pyrazofurin Biosynthesis Involves Nonenzymatic Ring Contraction of a Pyridazine Intermediate Triggered by a Rieske Enzyme-Catalyzed Oxygenation. [PDF]
Zheng Z, Lee YH, Ren D, Liu HW.
europepmc +1 more source
Shape-Conserving Atom Replacements. [PDF]
Puriņš M, Elgindy C, Levin MD.
europepmc +1 more source
Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M<sub>4</sub> Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust <i>In Vivo</i> Efficacy. [PDF]
Gregro AR +24 more
europepmc +1 more source

